BioCentury is featuring Inositec in this week’s emerging company profile. Read the article here (requires subscription).
- Inositec AG Appoints Dr Frits van Alphen as Chief Medical Officer
- Inositec wins Swiss Technology Award 2017
- Inositec featured in BioCentury
- Interview of Inositec CEO by Scrip Intelligence
- Inositec AG Secures CHF1.4 million in Seed Financing to Advance New Class of Inositol Hexaphosphate-Based Drug Candidates